New toolkit aims to end sickle cell trait disclosure gap

NCT ID NCT05387564

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a toolkit to help pediatric doctors document and discuss sickle cell trait results found during routine newborn screening. Researchers worked with 114 healthcare providers to see if the toolkit made it easier to share this information with families. The goal is to close a known gap where many people never learn their sickle cell trait status, despite being screened at birth.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
SCT Documentation and Disclosure Toolkit (behavioral intervention)
What this could lead to
If successful, this toolkit could help more families learn their child's sickle cell trait status early, enabling informed health decisions.
What could go wrong
This is a small, completed implementation study focused on provider behavior, not a treatment trial. Results may not apply to all clinics or guarantee long-term disclosure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL TRAIT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sickle Cell Trait

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nemours Children's Hospital, Delware

    Wilmington, Delaware, 19803, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.